chapter 1 Schizophrenic Syndromes -- chapter 2 General Overview of Contemporary Antipsychotic Medications -- chapter 3 Effects of Antipsychotic Drugs on Dopamine Release and Metabolism in the Central Nervous System -- chapter 4 Antipsychotic Drugs, Dopamine D2 Receptors, and Schizophrenia -- chapter 5 D1 Dopamine Receptors, Schizophrenia, and Antipsychotic Medications -- chapter 6 Serotonin Receptors as Targets of Antipsychotic Medications -- chapter 7 Role of Adrenergic Receptors in Effects of Antipsychotic Medications on Prefrontal Cortical Function -- chapter 8 Glutamate Receptors in Schizophrenia and Antipsychotic Drugs -- chapter 9 The Antipsychotic Effects of Sigma Drugs -- chapter 10 GABAergic Drugs in Schizophrenia -- chapter 11 Receptor Occupancy by Antipsychotics — Concepts and Findings -- chapter 12 Regulation of Neurotransmitter Receptors by Antipsychotic Drugs -- chapter 13 Modulation of Cellular Signaling Pathways by Antipsychotic Drugs -- chapter 14 The Role of Neurotransmitter Receptors in the Adversive Effects of Antipsychotic Drugs -- chapter 15 Future Perspectives in Antipsychotic Drug Development.